CPT® Code 79440

1. Indications

Radiopharmaceutical therapy by intra-articular administration is indicated for specific conditions related to joint health, particularly in patients with bleeding disorders. The following indications are explicitly recognized for this procedure:

• Recurrent Bleeding This therapy is utilized to manage recurrent bleeding episodes that are secondary to chronic synovitis, especially in individuals with hemophilia.
• Chronic Synovitis The procedure is indicated for patients suffering from chronic synovitis, which is an inflammation of the synovial membrane that can lead to joint pain and swelling.

2. Procedure

The procedure for radiopharmaceutical therapy by intra-articular administration involves several key steps to ensure effective treatment. Each step is crucial for the successful delivery of the radiolabeled compound into the joint space.

• Preparation of the Patient Prior to the procedure, the patient is assessed for their medical history and any contraindications to the therapy. Informed consent is obtained, and the patient is positioned comfortably to facilitate access to the targeted joint.
• Administration of Local Anesthesia Local anesthesia is administered to minimize discomfort during the injection. This step is essential for outpatient procedures, allowing the patient to remain awake and comfortable throughout the process.
• Injection of Radiopharmaceutical The radiolabeled compound, such as yttrium, gold, or phosphorus, is then injected directly into the joint space. The injection may be performed using a standard syringe or under radiological guidance, particularly for larger joints like the hip or shoulder, to ensure accurate placement.
• Post-Injection Monitoring After the injection, the patient is monitored for any immediate adverse reactions or complications. This monitoring is typically brief, especially in outpatient settings, where patients can often return home shortly after the procedure.

3. Post-Procedure

Following the radiopharmaceutical therapy, patients are advised on post-procedure care to ensure optimal recovery and effectiveness of the treatment. Patients may experience some localized discomfort or swelling at the injection site, which can be managed with ice packs and over-the-counter pain relief as needed. It is important for patients to follow any specific instructions provided by their healthcare provider regarding activity restrictions or follow-up appointments. Additionally, patients should be informed about potential side effects and when to seek medical attention, particularly if they experience unusual symptoms such as increased pain, swelling, or signs of infection in the treated joint.